Clinical Trials on GLENOID CAVITY

Total 952 results

Eli Lilly and Company

Completed

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States
Fred Hutchinson Cancer Center

Completed

Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Ovarian Cancer | Peritoneal Cavity Cancer

United States
University of Chicago
National Cancer Institute (NCI)

Active, not recruiting

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer

Tongue Cancer | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Squamous Cell... and other conditions

United States
University Hospital Freiburg
Boehringer Ingelheim

Terminated

EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye (EAGLE)

Stroke | Visual Acuity | Fibrinolysis | Retinal Artery Occlusion | Hemodilution

Germany, Switzerland, Austria
Vidya Raman

Completed

Interactive Perioperative Teaching Platform (IPTP)

Cryptorchidism | Hypospadias | Tonsillar Hypertrophy | Hydrocele | Adenoid Hypertrophy

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors

Oropharynx Cancer | Oral Cavity Cancer | Larynx Cancer | Hypopharynx Cancer

United States
European Organisation for Research and Treatment...

Completed

Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

Belgium, Netherlands, Spain
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Canada
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S9912 Combination Chemo in Stage III Ovarian Cancer,

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United States
Fred Hutchinson Cancer Center

Completed

Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United States
Craig L Slingluff, Jr
National Cancer Institute (NCI)

Terminated

Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Joseph Califano
Johns Hopkins University; NYU Langone Health; Greater Baltimore Medical Center; San Diego Veterans Healthcare System and other collaborators

Completed

Saliva-based Detection of CD44 (Detect 44)

Squamous Cell Carcinoma of the Head and Neck | Oropharynx Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | Squamous Cell Carcinoma of the Oropharynx

United States
M.D. Anderson Cancer Center
Pfizer; ISA Pharmaceuticals B.V.

Completed

Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer

Oropharyngeal Cancer | Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites | Malignant Neoplasms of Lip Oral Cavity and Pharynx

United States
National Cancer Institute (NCI)
Gynecologic Oncology Group

Completed

Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy

Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer

United States
AltaRex

Unknown

Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States, Canada
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Canada
Nordic Society of Gynaecological Oncology - Clinical...
European Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical...

Completed

Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

Italy, Canada, Israel, Norway, Belgium, Netherlands, Denmark, Portugal, Spain, United States
National Cancer Institute (NCI)

Terminated

EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer

Primary Peritoneal Cavity Cancer | Malignant Ascites | Recurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Localized Malignant Mesothelioma

United States
The University of Texas Health Science Center,...
Memorial Hermann Hospital

Terminated

Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study

Obstructive Sleep Apnea | Enlargement of Tonsil or Adenoid

United States
University Hospital, Limoges

Unknown

OCT and Microperimetry in Patients With Active Neovascular ARMD (CORFI) (CORFI)

Choroidal Neovascularization, Visual Field, Visual Acuity

France
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Pancreatic Adenocarcinoma | Stage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Malignant Neoplasm | Recurrent Colorectal Carcinoma | Pancreatic Neuroendocrine Carcinoma | Malignant Head and Neck Neoplasm | Stage III Nasopharyngeal Carcinoma... and other conditions

United States
Lumenis Be Ltd.

Completed

Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology

Skin Laxity | Muscle Contracture

United States
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)

Not yet recruiting

Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Gynecologic Cancer | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)

Completed

FT516 and IL2 With Enoblituzumab for Ovarian Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer | Fallopian Tube Adenocarcinoma

United States
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population

Oral Cavity Cancer | Oesophageal Cancer | Pharynx Cancer | Larynx Cancer

France
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer (S0009)

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States, Norway
National Cancer Institute (NCI)

Completed

Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer

United States
China Medical University Hospital

Not yet recruiting

Buyang Huanwu Decoction and Normal Tension Glaucoma

Glaucoma | Visual Acuity | Visual Field | Chinese Medicine
Galderma Brasil Ltda.

Recruiting

Retrospective Study of the Safety and Efficacy of PLLA for Skin Flaccidity in Labia Majora and/or Pubis Region

Skin Laxity

Brazil
Goldman, Butterwick, Fitzpatrick and Groff
Sofwave Medical LTD

Recruiting

High Intensity Ultrasound for the Treatment of Upper Inner Arm Skin Laxity

Skin Laxity

United States
InMode MD Ltd.

Completed

Evaluation of the Evoke Radiofrequency Device for Improvement of Skin Appearance

Skin Laxity

United States
Apyx Medical

Completed

Post-Market Lower Eyelid Treatment With Renuvion in Greece

Skin Laxity

Greece
Botanee Group Co., Ltd.

Completed

A Clinical Study on the Improvement of Skin and Living Conditions After Drinking Rosa Roxburghii and Pomegranate Drinks

Skin Laxity

China
Apyx Medical

Active, not recruiting

Measuring Renuvion Soft Tissue Contraction Using Ultrasound

Skin Laxity

United States
BTL Industries Ltd.

Completed

Radiofrequency and Ultrasound for Improvement of Skin Laxity and Wrinkles: Efficacy and Safety Evaluation

Skin Laxity

United States
University of Texas Southwestern Medical Center

Completed

Radio Frequency Microneedling for Suprapatellar Skin

Skin Laxity

United States
Recros Medica, Inc.

Unknown

The INFORM Study: Rotational Fractional Resection for Submental Contouring

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Heavy Water Tissue Labeling Protocol

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Lifting and Tightening of the Elbows

Skin Laxity

United States
Ulthera, Inc

Completed

Retrospective Evaluation of Combination Treatment With the Ulthera System

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Ulthera Treatment of the Buttocks and Thighs

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Evaluation of the Ulthera® System for Treatment of the Knees

Skin Laxity

United States
Cairo University

Recruiting

A Comparative Study of Visual Outcome of Two Extended Depth of Focus Intraocular Lenses After Cataract Surgery

Visual To Compare the Visual Outcome Between AcrySof™ IQ Vivity™ and TECNIS Synergy™ Intraocular Lens (Model ZFR00V )

Egypt
Goldman, Butterwick, Fitzpatrick and Groff
Galderma R&D

Not yet recruiting

Injectable Poly-L-Lactic Acid for Volumization and Adipogenesis of the Hip Dell

Skin Laxity

United States
University of Texas Southwestern Medical Center

Completed

Clinical Assessment of Skin Tightening and Contour Change of Submental Tissue Using Bipolar Radiofrequency Microneedling

Skin Laxity

United States
BTL Industries Ltd.

Completed

Safety and Efficacy of the BTL-785F Device for Non-invasive Reduction of Submental Fat

Skin Laxity

Bulgaria
Cynosure, Inc.

Completed

Rollover Study to Evaluate Histological Results of Radiofrequency Device Treatments on the Flanks

Skin Laxity

United States
Northwestern University

Withdrawn

Combination of Ultrasound Treatment and Neck Liposuction for Skin Tightening

Skin Laxity
R2 Dermatology

Completed

Dermal Cryotherapy in Patients Undergoing Abdominoplasty

Skin Laxity

United States

Clinical Trials on GLENOID CAVITY

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations